A recent JAMA study suggests that prostate-specific antigen (PSA) screening may miss early-stage prostate cancer in transgender women receiving hormonal therapy with estrogen.1The highest...
Investigators have developed and validated a 15-gene prognostic signature that was shown to be independently associated with worse disease-free survival (DFS) and disease-specific survival...
In this video, Justin M. Dubin, MD, discusses the rationale for the study, “Beyond the prescription: trends and challenges in erectile dysfunction medications among...
